Delivery Order SPE2DB24D8001-SPE2DB24FKZAE
Award Date
9/6/24
Potential Completion Date
9/9/24
Potential Value
$8.1K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of STELARA 90 MG/ML syringes. The $8,187.08 firm-fixed price award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00. This IDC allows Dakota Drug, Inc. to provide a wide range of pharmaceutical products, medical supplies, and healthcare...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $10,986.80 contract is for the supply of STELARA 90 MG/ML syringes, a biologic medication used to treat rheumatoid arthritis and other medical conditions. This delivery order is issued against Dakota Drug, Inc.'s blanket purchase agreement and other DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $19,196.40, is for the delivery of STELARA 90 MG/ML SYRINGEML medical supplies. The contract is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is under the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $16,170.78, is for the supply of Stelara 90 mg/mL syringes. The award is part of DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) with a ceiling value of $999,999,999.00 that allows Dakota Drug, Inc. to provide a comprehensive range of...
This is a $11,114.44 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a small disadvantaged business, for the supply of STELARA 90 MG/ML syringes. The contract has an ultimate completion date of May 2, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense, with a significant single-award Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $8,445.88, is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a performance period ending on March 18, 2025. The contract is a delivery order issued under Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, which has a total potential value of...
This is a $18,214.10 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of the pharmaceutical product Stelara 90 mg/ml syringe. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA Troop Support Medical's ECAT Generation V Program. This IDC...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of STELARA 90 MG/ML syringes. The contract has a ceiling value of $12,117.01 and a period of performance extending through November 13, 2024. Dakota Drug, Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which enables the company to provide a comprehensive...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Stelara 90 mg/mL syringes, with a completion date of November 2, 2023, and a ceiling value of $8,600.28. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense. The company holds a...
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical division. The contract, valued at $13,608.63, was awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, on February 23, 2024, with a performance period ending on February 26, 2024. The contract is a delivery order under Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as...